Four SPORE Grants Will Support Ovarian Cancer Research

BETHESDA, Md—Four institutions have received SPORE (Specialized Program of Research Excellence) grants from the NCI for ovarian cancer research. The grants, totaling $5.85 million for the first year, went to:

The University of Texas M.D. An-derson Cancer Center, to pursue chemo-prevention, antiangiogenesis, and novel treatments for the disease.

Fred Hutchinson Cancer Research Center, to establish the Pacific Ovarian Cancer Research Consortium, whose efforts will include studies of genes responsible for resistance to chemotherapy and the development of a nucleic acid vaccine for prevention of the disease.

Fox Chase Cancer Center, to develop an interdisciplinary ovarian cancer program focused on carcinogenesis, prevention, and treatment of the cancer.

The University of Alabama at Birmingham, for the development of a new genetically engineered monoclonal antibody therapy, targeted immunotherapy, and research to find markers of disease progression that can be used as targets for chemoprevention.